TY - JOUR T1 - A modified SEIR model to predict the COVID-19 outbreak in Spain: simulating control scenarios and multi-scale epidemics JF - medRxiv DO - 10.1101/2020.03.27.20045005 SP - 2020.03.27.20045005 AU - Leonardo López AU - Xavier Rodó Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/03/30/2020.03.27.20045005.abstract N2 - After the spread of SARS-CoV-2 epidemic out of China, evolution in the pandemic worldwide shows dramatic differences among countries. In Europe, the situation of Italy first and later Spain has generated great concern, and despite other countries show better prospects, large uncertainties yet remain on the future evolution and the efficacy of containment, mitigation or attack strategies. Here we applied a modified SEIR compartmental model accounting for the spread of infection during the latent period, in which we also incorporate effects of varying proportions of containment. We fit data to quarantined populations in order to account for the uncertainties in case reporting and study the scenario projections for the 17 individual regions (CCAA). Results indicate that with data for March 23, the epidemics follows an evolution similar to the isolation of 1, 5 percent of the population and if there were no effects of intervention actions it might reach a maximum over 1.4M infected around April27. The effect on the epidemics of the ongoing partial confinement measures is yet unknown, but increasing the isolation around ten times more could drastically reduce the peak to over 100k cases by early April, while each day of delay in taking this hard containment scenario represents an 90 percent increase of the infected population at the peak. Dynamics at the sub aggregated levels of CCAA show epidemics at the different levels of progression with the most worrying situation in Madrid an Catalonia. Increasing alpha values up to 10 times, in addition to a drastic reduction in clinical cases, would also more than halve the number of deaths.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has not have been founded by any particular organization.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data come from open data sources that are linked bellow. https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/home.htm https://experience.arcgis.com/experience/50d6c4c5599a43f4bebf517daa3a97b6 https://grafana.sysadm.es/d/Y9Anj9_Wz2dsadasDXCAxz5/coronavirus-spain?orgId=4&refresh=1h ER -